Outcome after surgical embolectomy for acute pulmonary embolism.


Journal

Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752

Informations de publication

Date de publication:
01 08 2022
Historique:
pubmed: 30 7 2022
medline: 3 8 2022
entrez: 29 7 2022
Statut: ppublish

Résumé

Patients with pulmonary embolism (PE) and contraindications for or failed thrombolysis are at the highest risk for PE-related fatal events. These patients may benefit from surgical embolectomy, but data concerning this approach are still limited. The method used here was retrospective data analysis of 103 patients who underwent surgical embolectomy from 2002 to 2020 at our department. Mean age was 58.4 (±15.1) years. Fifty-eight (56.3%) patients had undergone recent surgery; the surgery was tumor associated in 32 (31.1%) cases. Thirty (29.1%) patients had to be resuscitated due to PE, and 13 (12.6%) patients underwent thrombolysis prior to pulmonary embolectomy. Fifteen (14.5%) patients were placed on extra corporeal membrane oxygenation (ECMO) peri-operatively. Five patients (4.9%) died intra-operatively. Neurological symptoms occurred in four patients (3.9%). Thirty-day mortality was 23.3% ( n  = 24). Re-thoracotomy due to bleeding was necessary in 12 (11.6%) patients. This parameter was also identified as an independent risk factor for mortality. Surgical pulmonary embolectomy resulted in survival of the majority of patients with PE and contraindications for or failed thrombolysis. Given the excessive mortality when left untreated, an operative approach should become a routine part of discussions concerning alternative treatment options for these patients.

Identifiants

pubmed: 35905002
doi: 10.2459/JCM.0000000000001349
pii: 01244665-202208000-00004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-523

Informations de copyright

Copyright © 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.

Références

Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res 2016.
Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 2020.
Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 2015; 36:605–614.
Choi JH, O’Malley TJ, Maynes EJ, et al. Surgical pulmonary embolectomy outcomes for acute pulmonary embolism. Ann Thorac Surg 2020; 110:1072–1080.
Lee T, Itagaki S, Chiang YP, Egorova NN, Adams DH, Chikwe J. Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013. J Thorac Cardiovasc Surg 2018.
Konstantinides S, Meyer v, Bueno G, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J 2020.
Nicolaides A, Fareed J, Kakkar AK, et al. Surgical thrombectomy. Clin Appl Thromb/Hemost 2013; 19:205–206.
Becattini C, Agnelli G, Germini F, Vedovati MC. Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. Eur Respir J 2014; 43:1678–1690.
ten Wolde M, Söhne M, Quak E, mac Gillavry MR, Büller HR. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism. Arch Intern Med 2004; 164:1685–1689.
Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012.
Deas DS, Keeling B. Surgical pulmonary embolectomy. Crit Care Clin 2020; 36:497–504.
Goldhaber SZ. Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. Texas Heart Inst J 2013; 40:5–8.
Lee T, Itagaki S, Chiang YP, Egorova NN, Adams DH, Chikwe J. Survival and recurrence after acute pulmonary embolism treated with pulmonary embolectomy or thrombolysis in New York State, 1999 to 2013. J Thorac Cardiovasc Surg 2018; 155:1084–1090.
Ius F, Hoeper MM, Fegbeutel C, et al. Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism. Eur Respir J 2019.
Meneveau N, Guillon B, Planquette B, et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J 2018.
Al-Bawardy R, Rosenfield K, Borges J, et al. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a case series and review of the literature. Perfusion (United Kingdom) 2019.
Kmiec L, Philipp A, Floerchinger B, et al. Extracorporeal membrane oxygenation for massive pulmonary embolism as bridge to therapy. ASAIO J 2020; 66:146–152.
Cho YH, Sung K, Kim WS, et al. Management of acute massive pulmonary embolism: Is surgical embolectomy inferior to thrombolysis? Int J Cardiol 2016; 203:579–583.
Provias T, Dudzinski DM, Jaff MR, et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract 2014; 42:31–37.
Kabrhel C, Rosovsky R, Channick R, et al. A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 2016; 150:384–393.

Auteurs

Bernd Panholzer (B)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Hanna Gravert (H)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Christoph Borzikowsky (C)

Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein.

Katharina Huenges (K)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Jan Schoettler (J)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Felix Schoeneich (F)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Tim Attmann (T)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Assad Haneya (A)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Derk Frank (D)

Department of Internal Medicine III/Cardiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany and DZHK, partner site Hamburg, Kiel, Lübeck.

Jochen Cremer (J)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.

Christina Grothusen (C)

Department of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel.
Medizinische Klinik I, St. Johannes Hospital Dortmund, Dortmund, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH